VÉTOQUINOL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
VÉTOQUINOL
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2023 compared with 2022filed annual accounts (NBB)
Net result for the year
€527,980
2022 · €251,391+€276,589
Equity
€280,006
2022 · €279,026+€980
Cash
-
not filed
Balance sheet total
€5.2m
2022 · €6.1m-€952,173
Largest movements
Assets
- Stocks and contracts -€2.1m
down €2.1m (-57.6%), from €3.7m to €1.5m
- Receivables within one year +€1.2m
up €1.2m (+57.3%), from €2.1m to €3.3m
of which Other amounts receivable: +€831,680
Equity and liabilities
- Other debts -€2.2m
down €2.2m (-80.5%), from €2.7m to €527,000
- Trade debts +€1.3m
up €1.3m (+67.8%), from €1.9m to €3.1m
Income statement
- Goods and materials +€733,672
up €733,672 (+7.1%), from €10.3m to €11.0m
of which Change in stocks: decrease (increase): +€1.0m
- Turnover +€558,459
up €558,459 (+3.4%), from €16.3m to €16.8m
- Other operating income +€467,156
up €467,156 (+34.4%), from €1.4m to €1.8m
- Staff costs +€431,244
up €431,244 (+11.2%), from €3.8m to €4.3m
- Services and other goods -€280,656
down €280,656 (-10.8%), from €2.6m to €2.3m
From the 2022 result to the 2023 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2022
€251,391
Turnover
+€558,459
Other operating income
+€467,156
Goods and materials
-€733,672
Services and other goods
+€280,656
Staff costs
-€431,244
Depreciation
-€12,750
Write-downs
+€228,841
Provisions
+€17,375
Other operating charges
-€28,829
Other operating items
-€3,471
Financial income
+€966
Financial charges
-€19,834
Taxes
-€47,064
Result 2023
€527,980
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2022 | 2023 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,105,640 | €5,153,467 | -€952,173 | -15.6% |
| Fixed assets | 21/28 | €287,729 | €227,151 | -€60,578 | -21.1% |
| Intangible fixed assets | 21 | €29,436 | €1,115 | -€28,321 | -96.2% |
| Tangible fixed assets | 22/27 | €257,966 | €226,036 | -€31,930 | -12.4% |
| Plant, machinery and equipment | 23 | €257,966 | €226,036 | -€31,930 | -12.4% |
| Financial fixed assets | 28 | €327 | - | -€327 | |
| Other financial fixed assets | 284/8 | €327 | - | -€327 | |
| Amounts receivable and cash guarantees | 285/8 | €327 | - | -€327 | |
| Current assets | 29/58 | €5,817,911 | €4,926,316 | -€891,595 | -15.3% |
| Stocks and contracts in progress | 3 | €3,657,178 | €1,549,030 | -€2.1m | -57.6% |
| Stocks | 30/36 | €3,657,178 | €1,549,030 | -€2.1m | -57.6% |
| Goods purchased for resale | 34 | €3,657,178 | €1,549,030 | -€2.1m | -57.6% |
| Amounts receivable within one year | 40/41 | €2,117,280 | €3,329,738 | +€1.2m | +57.3% |
| Trade receivables | 40 | €1,889,622 | €2,270,400 | +€380,778 | +20.2% |
| Other amounts receivable | 41 | €227,658 | €1,059,338 | +€831,680 | +365% |
| Deferred charges and accrued income | 490/1 | €43,453 | €47,548 | +€4,095 | +9.4% |
| Total equity and liabilities | 10/49 | €6,105,640 | €5,153,467 | -€952,173 | -15.6% |
| Equity | 10/15 | €279,026 | €280,006 | +€980 | +0.4% |
| Contributions | 10/11 | €87,000 | €87,000 | = | 0.0% |
| Capital | 10 | €87,000 | €87,000 | = | 0.0% |
| Issued capital | 100 | €87,000 | €87,000 | = | 0.0% |
| Reserves | 13 | €190,635 | €190,635 | = | 0.0% |
| Non-distributable reserves | 130/1 | €8,700 | €8,700 | = | 0.0% |
| Legal reserve | 130 | €8,700 | €8,700 | = | 0.0% |
| Tax-exempt reserves | 132 | €7,437 | €7,437 | = | 0.0% |
| Distributable reserves | 133 | €174,498 | €174,498 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,391 | €2,371 | +€980 | +70.5% |
| Provisions and deferred taxes | 16 | €25,623 | €25,623 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €25,623 | €25,623 | = | 0.0% |
| Other liabilities and charges | 164/5 | €25,623 | €25,623 | = | 0.0% |
| Amounts payable | 17/49 | €5,800,991 | €4,847,838 | -€953,153 | -16.4% |
| Amounts payable within one year | 42/48 | €5,787,160 | €4,835,735 | -€951,425 | -16.4% |
| Trade debts | 44 | €1,864,718 | €3,129,627 | +€1.3m | +67.8% |
| Suppliers | 440/4 | €1,864,718 | €3,129,627 | +€1.3m | +67.8% |
| Taxes, remuneration and social security | 45 | €1,222,413 | €1,179,108 | -€43,305 | -3.5% |
| Taxes | 450/3 | €126,546 | €105,584 | -€20,962 | -16.6% |
| Remuneration and social security | 454/9 | €1,095,867 | €1,073,524 | -€22,343 | -2.0% |
| Other amounts payable | 47/48 | €2,700,029 | €527,000 | -€2.2m | -80.5% |
| Accrued charges and deferred income | 492/3 | €13,831 | €12,103 | -€1,728 | -12.5% |
| Operating income | 70/76A | €17,612,570 | €18,634,714 | +€1.0m | +5.8% |
| Turnover | 70 | €16,252,031 | €16,810,490 | +€558,459 | +3.4% |
| Other operating income | 74 | €1,357,068 | €1,824,224 | +€467,156 | +34.4% |
| Non-recurring operating income | 76A | €3,471 | - | -€3,471 | |
| Operating charges | 60/66A | €16,982,513 | €17,662,136 | +€679,623 | +4.0% |
| Goods for resale, raw materials and consumables | 60 | €10,281,667 | €11,015,339 | +€733,672 | +7.1% |
| Purchases | 600/8 | €9,103,431 | €8,829,246 | -€274,185 | -3.0% |
| Change in stocks: decrease (increase) | 609 | €1,178,236 | €2,186,093 | +€1.0m | +85.5% |
| Services and other goods | 61 | €2,597,448 | €2,316,792 | -€280,656 | -10.8% |
| Remuneration, social security and pensions | 62 | €3,842,521 | €4,273,765 | +€431,244 | +11.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €68,829 | €81,579 | +€12,750 | +18.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €150,896 | -€77,945 | -€228,841 | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €17,375 | - | -€17,375 | |
| Other operating charges | 640/8 | €23,777 | €52,606 | +€28,829 | +121% |
| Operating profit (loss) | 9901 | €630,057 | €972,578 | +€342,521 | +54.4% |
| Financial income | 75/76B | €240 | €1,206 | +€966 | +403% |
| Recurring financial income | 75 | €240 | €1,206 | +€966 | +403% |
| Other financial income | 752/9 | €240 | €1,206 | +€966 | +403% |
| Financial charges | 65/66B | €109,651 | €129,485 | +€19,834 | +18.1% |
| Recurring financial charges | 65 | €109,651 | €129,485 | +€19,834 | +18.1% |
| Debt charges | 650 | €14,625 | €41,803 | +€27,178 | +186% |
| Other financial charges | 652/9 | €95,026 | €87,682 | -€7,344 | -7.7% |
| Profit (loss) for the period before taxes | 9903 | €520,646 | €844,299 | +€323,653 | +62.2% |
| Income taxes | 67/77 | €269,255 | €316,319 | +€47,064 | +17.5% |
| Taxes | 670/3 | €269,255 | €316,319 | +€47,064 | +17.5% |
| Profit (loss) for the period | 9904 | €251,391 | €527,980 | +€276,589 | +110% |
| Profit (loss) for the period to be appropriated | 9905 | €251,391 | €527,980 | +€276,589 | +110% |
Source: filed annual accounts (NBB), financial years ended 31 December 2022 and 31 December 2023. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.